HBM BIOVENTURES CAYMAN LTD 13D and 13G filings for Longboard Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:07 pm Sale |
2024-02-06 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
HBM BIOVENTURES CAYMAN LTD | 0 0.000% |
-1,345,009 (Position Closed) |
Filing |
| 2023-02-14 4:01 pm Purchase |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
HBM BIOVENTURES CAYMAN LTD | 1,345,009 9.990% |
17,579 (+1.32%) |
Filing |
| 2021-03-22 4:23 pm Purchase |
2021-03-12 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
HBM BIOVENTURES CAYMAN LTD | 1,327,430 9.990% |
1,327,430 (New Position) |
Filing |